This has significantly enhanced technical and production capacities, enabling the country to achieve 91% self-sufficiency in medicine.
The Information and Decision Support Center (IDSC) of the Egyptian Cabinet has announced that Egypt has successfully established a solid industrial base in the pharmaceutical sector over recent years. This has significantly enhanced technical and production capacities, enabling the country to achieve 91% self-sufficiency in medicine.
Egypt now hosts more than 179 pharmaceutical factories, including 11 facilities with international accreditations, in addition to 150 medical supplies factories, 5 plants specializing in raw materials, 4 facilities dedicated to biological products, and over 986 pharmaceutical production lines.
Notably, the government has decided to increase the healthcare sector budget by 24.9% in the new 2024/2025 fiscal year, bringing the allocation to approximately EGP 496 billion, up from EGP 397 billion in 2023/2024.
This fulfills the constitutional allocation requirement for the health sector in the new state budget.
Furthermore, the government will continue to implement the state-funded medical treatment program without interruption, with its allocation increasing by 16.1% to reach EGP 10.1 billion in the 2024/2025 budget, compared to EGP 8.7 billion in the previous fiscal year.
